loading

Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.63%
0.898
0.875 1.299 1.614 1.95
Operating Expenses
6.21%
45.86
43.18 43.51 48.66 48.80
Operating Income/Loss
6.29%
-44.96
-42.30 -42.21 -47.05 -46.85
Income Tax Expense/Benefit
7.89%
0.035
0.038 0.092 0.654 0.178
Net Income/Loss
7.67%
-42.76
-39.72 -39.16 -44.13 -43.10
Basic Average Shares
0.92%
42.22
41.84 0.0784 41.46 41.34
Diluted Average Shares
0.92%
42.22
41.84 0.0784 41.46 41.34
Basic Earnings Per Share
6.32%
-1.01
-0.95 -0.94 -1.06 -1.04
Diluted Earnings Per Share
6.32%
-1.01
-0.95 -0.94 -1.06 -1.04
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):